Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Byrne

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Clinical Obstetrics and Gynecology|September 1, 1994
Genetic factors in recurrent abortionJ L Byrne, K Ward
American Journal of Surgery|February 1, 1989
External carotid endarterectomy under direct visionJ L Byrne, S N Zaman
Bone Marrow Transplantation|November 2, 2004
In vivo Campath for the prevention of GvHD following allogeneic HSCT: effects of dose, schedule and antibody typeN H Russell, J L Byrne
Best Practice & Research. Clinical Haematology|April 2, 2002
Allogeneic transplantation using peripheral blood stem cellsN H Russell, J L Byrne
British Journal of Haematology|March 6, 1998
The molecular pathophysiology of myeloid leukaemias: Ras revisitedJ L Byrne, C J Marshall
Journal of Clinical Pathology|August 26, 1998
Peripheral blood stem cell transplantsJ L Byrne, N H Russell
Bone Marrow Transplantation|December 7, 2000
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in lymphoma without blood product supportA Sefcick, J L Byrne, N H Russell
Canadian Journal of Comparative Medicine and Veterinary Science|October 29, 2010
Studies in infectious mastitis; penicillin as a therapeutic agentJ L BYRNE, J W PULLIN, H KONSK
Blood Reviews|March 1, 1997
Use of haemopoietic growth factors: commentary on the ASCO/ECOG guidelines. American Society of Clinical Oncology/Eastern Co-operative Oncology GroupJ L Byrne, A P Haynes, N H Russell
Oncogene|November 21, 1996
p21Ras activation by the guanine nucleotide exchange factor Sos, requires the Sos/Grb2 interaction and a second ligand-dependent signal involving the Sos N-terminusJ L Byrne, H F Paterson, C J Marshall
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Clinical Obstetrics and Gynecology|September 1, 1994
Genetic factors in recurrent abortionJ L Byrne, K Ward
American Journal of Surgery|February 1, 1989
External carotid endarterectomy under direct visionJ L Byrne, S N Zaman
Bone Marrow Transplantation|November 2, 2004
In vivo Campath for the prevention of GvHD following allogeneic HSCT: effects of dose, schedule and antibody typeN H Russell, J L Byrne
Best Practice & Research. Clinical Haematology|April 2, 2002
Allogeneic transplantation using peripheral blood stem cellsN H Russell, J L Byrne
British Journal of Haematology|March 6, 1998
The molecular pathophysiology of myeloid leukaemias: Ras revisitedJ L Byrne, C J Marshall
Journal of Clinical Pathology|August 26, 1998
Peripheral blood stem cell transplantsJ L Byrne, N H Russell
Bone Marrow Transplantation|December 7, 2000
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in lymphoma without blood product supportA Sefcick, J L Byrne, N H Russell
Canadian Journal of Comparative Medicine and Veterinary Science|October 29, 2010
Studies in infectious mastitis; penicillin as a therapeutic agentJ L BYRNE, J W PULLIN, H KONSK
Blood Reviews|March 1, 1997
Use of haemopoietic growth factors: commentary on the ASCO/ECOG guidelines. American Society of Clinical Oncology/Eastern Co-operative Oncology GroupJ L Byrne, A P Haynes, N H Russell
Oncogene|November 21, 1996
p21Ras activation by the guanine nucleotide exchange factor Sos, requires the Sos/Grb2 interaction and a second ligand-dependent signal involving the Sos N-terminusJ L Byrne, H F Paterson, C J Marshall
Pageof 6